1290 Essex Small Cap Growth Fund Class R ESCKX

Medalist Rating as of | See 1290 Funds Investment Hub
  • NAV / 1-Day Return 18.27  /  +0.10 %
  • Total Assets 115.2M
  • Adj. Expense Ratio
    1.380%
  • Expense Ratio 1.380%
  • Distribution Fee Level Average
  • Share Class Type Retirement, Medium
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 55%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 3:34 AM GMT+0

Morningstar’s Analysis ESCKX

Will ESCKX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

1290 Essex Small Cap Growth R holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ESCKX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 20.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Kiniksa Pharmaceuticals International PLC Class A

2.74 3M
Healthcare

Adaptive Biotechnologies Corp

2.45 3M
Healthcare

JPMorgan Prime Money Market IM

2.33 3M
Cash and Equivalents

CECO Environmental Corp

2.24 3M
Industrials

Travere Therapeutics Inc Ordinary Shares

1.97 2M
Healthcare

Leonardo DRS Inc

1.96 2M
Industrials

Oceaneering International Inc

1.72 2M
Energy

BrainsWay Ltd ADR

1.72 2M
Healthcare

Tower Semiconductor Ltd

1.57 2M
Technology

Lincoln Educational Services Corp

1.52 2M
Consumer Defensive

Sponsor Center